Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

RGNX - REGENXBIO Inc.


IEX Last Trade
7.475
-0.025   -0.334%

Share volume: 6,598
Last Updated: Fri 27 Dec 2024 05:30:13 PM CET
Research and Development in Biotechnology (except Nanobiotechnology): -0.39%

PREVIOUS CLOSE
CHG
CHG%

$7.50
-0.03
-0.33%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31 2024-06-30
Fiscal Quarter Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024
Report Date 2022-11-03 2023-02-28 2023-05-03 2023-08-02 2023-11-08 2024-02-27 2024-05-08 2024-08-01
Total revenue 26.512 M 31.345 M 19.138 M 19.977 M 28.914 M 22.213 M 15.622 M 22.295 M
Cost of revenue 13.323 M 12.080 M 4.112 M 9.475 M 12.388 M 11.238 M 4.283 M 10.579 M
Gross profit 13.189 M 19.265 M 15.026 M 10.502 M 16.526 M 10.975 M 11.339 M 11.716 M
    46.07% -22.00% -30.11% 57.36% -33.59% 3.32% 3.32%  
Operating expenses 84.234 M 83.715 M 81.150 M 83.584 M 81.266 M 74.760 M 73.135 M 67.724 M
Selling general and admin 20.921 M 21.210 M 22.634 M 23.698 M 23.083 M 19.079 M 18.291 M 18.855 M
Research and development 63.313 M 62.505 M 58.516 M 59.886 M 58.183 M 55.681 M 54.844 M 48.869 M
Total expenses 97.557 M 89.116 M 85.295 M 93.085 M 93.874 M 86.116 M 77.384 M 78.332 M
    -8.65% -4.29% 9.13% 0.85% -8.26% -10.14% 1.23%  
Operating income -71.045 M -57.771 M -66.157 M -73.108 M -64.960 M -63.903 M -61.762 M -56.037 M
Ebit -71.045 M -57.771 M -66.157 M -73.108 M -64.960 M -63.903 M -61.762 M -56.037 M
Pretax income -75.484 M -59.978 M -66.676 M -72.061 M -61.868 M -63.041 M -63.330 M -52.989 M
    -20.54% 11.17% 8.08% -14.14% 1.90% 0.46% -16.33%  
Income tax 0.000 -43.000 K 0.000 0.000 0.000 -152.000 K 0.000 0.000
Net income basic -75.484 M -59.935 M -66.676 M -72.061 M -61.868 M -62.889 M -63.330 M -52.989 M
    20.60% -11.25% -8.08% 14.14% -1.65% -0.70% 16.33%  
Net income -75.484 M -59.935 M -66.676 M -72.061 M -61.868 M -62.889 M -63.330 M -52.989 M
    20.60% -11.25% -8.08% 14.14% -1.65% -0.70% 16.33%